Loading…

Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy

Laboratory data and prior pediatric reports indicate that HIV protease inhibitor (PI)-based antiretroviral therapy (ARV) kills gametocytes and reduces rates of gametocytemia, but not asymptomatic parasitemia, in a high malaria-transmission area. To determine whether ARV regimen impacts these rates i...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of tropical medicine and hygiene 2018-01, Vol.98 (1), p.67-70
Main Authors: Hobbs, Charlotte V, Gabriel, Erin E, Kamthunzi, Portia, Tegha, Gerald, Tauzie, Jean, Li, Yonghua, Ilmet, Tiina, Artimovich, Elena, Neal, Jillian, Hall, Ted, Parikh, Sunil, Kirmse, Brian, Jean-Philippe, Patrick, Chen, Jingyang, Prescott, William R, Palumbo, Paul, Duffy, Patrick E, Borkowsky, William, For The P S Study Team
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-10eb90ffa882cc597c507ba77453a35c0c812ae3c3f40bf2c476619b4e405e453
cites
container_end_page 70
container_issue 1
container_start_page 67
container_title The American journal of tropical medicine and hygiene
container_volume 98
creator Hobbs, Charlotte V
Gabriel, Erin E
Kamthunzi, Portia
Tegha, Gerald
Tauzie, Jean
Li, Yonghua
Ilmet, Tiina
Artimovich, Elena
Neal, Jillian
Hall, Ted
Parikh, Sunil
Kirmse, Brian
Jean-Philippe, Patrick
Chen, Jingyang
Prescott, William R
Palumbo, Paul
Duffy, Patrick E
Borkowsky, William
For The P S Study Team
description Laboratory data and prior pediatric reports indicate that HIV protease inhibitor (PI)-based antiretroviral therapy (ARV) kills gametocytes and reduces rates of gametocytemia, but not asymptomatic parasitemia, in a high malaria-transmission area. To determine whether ARV regimen impacts these rates in areas with less-intense malaria transmission, we compared asymptomatic parasitemia and gametocytemia rates in HIV-infected children by ARV regimen in Lilongwe, Malawi, an area of low-to-moderate transmission intensity. HIV PI lopinavir-ritonavir (LPV-rtv) ARV- or non-nucleoside reverse transcriptase inhibitor nevirapine ARV-treated children did not differ in the rates of polymerase chain reaction-detected asymptomatic parasitemia (relative risk [RR] 0.43 95% confidence interval [CI] [0.16, 1.18], value 0.10) or microscopically detected gametocytemia with LPV-rtv ARV during symptomatic malaria (RR 0.48 95% CI [0.22,1.04] value 0.06). LPV-rtv ARV was not associated with reduced rates of asymptomatic parasitemia, or gametocytemia on days of symptomatic malaria episodes, in HIV-infected children. Larger studies should evaluate whether ARV impacts transmission.
doi_str_mv 10.4269/ajtmh.17-0462
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5928720</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2116059339</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-10eb90ffa882cc597c507ba77453a35c0c812ae3c3f40bf2c476619b4e405e453</originalsourceid><addsrcrecordid>eNpdkc1vEzEQxS0EoqFw5IosceGyxR_r9fqCFAXaRqpED4Wr5XXGjaNdO9jeSPnvcZtSAaeRZn56mvceQu8puWhZpz6bXZm2F1Q2pO3YC7Sgrewa2rXiJVoQQlijOi7P0Jucd4TQnlH6Gp0xRTvBmFig-TbBwYwQLODo8DIfp32Jkyne4luTTPYFJm-wCRt8ZSYo0R5PGx_w9fpnsw4ObIENXm39uEkQcAz4q3cOkg_3eBmKT1BSPPhkRny3hWT2x7folTNjhndP8xz9uPx2t7pubr5frVfLm8a2VJSGEhgUcc70PbNWKGkFkYORshXccGGJ7SkzwC13LRkcs9V7R9XQQksEVOgcfTnp7udhgo2FUOoXep_8ZNJRR-P1v5fgt_o-HrRQrJeMVIFPTwIp_pohFz35bGEcTYA4Z01VJ2vunNCKfvwP3cU5hWpP19A7IhTnqlLNibIp5pzAPT9DiX4oVD8WqqnUD4VW_sPfDp7pPw3y37nynp8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2116059339</pqid></control><display><type>article</type><title>Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy</title><source>PubMed Central Free</source><creator>Hobbs, Charlotte V ; Gabriel, Erin E ; Kamthunzi, Portia ; Tegha, Gerald ; Tauzie, Jean ; Li, Yonghua ; Ilmet, Tiina ; Artimovich, Elena ; Neal, Jillian ; Hall, Ted ; Parikh, Sunil ; Kirmse, Brian ; Jean-Philippe, Patrick ; Chen, Jingyang ; Prescott, William R ; Palumbo, Paul ; Duffy, Patrick E ; Borkowsky, William ; For The P S Study Team</creator><creatorcontrib>Hobbs, Charlotte V ; Gabriel, Erin E ; Kamthunzi, Portia ; Tegha, Gerald ; Tauzie, Jean ; Li, Yonghua ; Ilmet, Tiina ; Artimovich, Elena ; Neal, Jillian ; Hall, Ted ; Parikh, Sunil ; Kirmse, Brian ; Jean-Philippe, Patrick ; Chen, Jingyang ; Prescott, William R ; Palumbo, Paul ; Duffy, Patrick E ; Borkowsky, William ; For The P S Study Team</creatorcontrib><description>Laboratory data and prior pediatric reports indicate that HIV protease inhibitor (PI)-based antiretroviral therapy (ARV) kills gametocytes and reduces rates of gametocytemia, but not asymptomatic parasitemia, in a high malaria-transmission area. To determine whether ARV regimen impacts these rates in areas with less-intense malaria transmission, we compared asymptomatic parasitemia and gametocytemia rates in HIV-infected children by ARV regimen in Lilongwe, Malawi, an area of low-to-moderate transmission intensity. HIV PI lopinavir-ritonavir (LPV-rtv) ARV- or non-nucleoside reverse transcriptase inhibitor nevirapine ARV-treated children did not differ in the rates of polymerase chain reaction-detected asymptomatic parasitemia (relative risk [RR] 0.43 95% confidence interval [CI] [0.16, 1.18], value 0.10) or microscopically detected gametocytemia with LPV-rtv ARV during symptomatic malaria (RR 0.48 95% CI [0.22,1.04] value 0.06). LPV-rtv ARV was not associated with reduced rates of asymptomatic parasitemia, or gametocytemia on days of symptomatic malaria episodes, in HIV-infected children. Larger studies should evaluate whether ARV impacts transmission.</description><identifier>ISSN: 0002-9637</identifier><identifier>EISSN: 1476-1645</identifier><identifier>DOI: 10.4269/ajtmh.17-0462</identifier><identifier>PMID: 29165225</identifier><language>eng</language><publisher>United States: Institute of Tropical Medicine</publisher><subject>Africa South of the Sahara - epidemiology ; Anti-HIV Agents - therapeutic use ; Antiretroviral drugs ; Asymptomatic Infections - epidemiology ; Child, Preschool ; Coinfection - epidemiology ; Coinfection - parasitology ; Coinfection - virology ; Drug therapy ; Female ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Infections - parasitology ; Humans ; Infant ; Malaria ; Malaria, Falciparum - complications ; Malaria, Falciparum - epidemiology ; Male ; Microsatellite Repeats - genetics ; Parasitemia - epidemiology ; Plasmodium falciparum - genetics ; Prevalence ; Protease inhibitors</subject><ispartof>The American journal of tropical medicine and hygiene, 2018-01, Vol.98 (1), p.67-70</ispartof><rights>Copyright Institute of Tropical Medicine 2018</rights><rights>The American Society of Tropical Medicine and Hygiene 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-10eb90ffa882cc597c507ba77453a35c0c812ae3c3f40bf2c476619b4e405e453</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928720/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928720/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29165225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hobbs, Charlotte V</creatorcontrib><creatorcontrib>Gabriel, Erin E</creatorcontrib><creatorcontrib>Kamthunzi, Portia</creatorcontrib><creatorcontrib>Tegha, Gerald</creatorcontrib><creatorcontrib>Tauzie, Jean</creatorcontrib><creatorcontrib>Li, Yonghua</creatorcontrib><creatorcontrib>Ilmet, Tiina</creatorcontrib><creatorcontrib>Artimovich, Elena</creatorcontrib><creatorcontrib>Neal, Jillian</creatorcontrib><creatorcontrib>Hall, Ted</creatorcontrib><creatorcontrib>Parikh, Sunil</creatorcontrib><creatorcontrib>Kirmse, Brian</creatorcontrib><creatorcontrib>Jean-Philippe, Patrick</creatorcontrib><creatorcontrib>Chen, Jingyang</creatorcontrib><creatorcontrib>Prescott, William R</creatorcontrib><creatorcontrib>Palumbo, Paul</creatorcontrib><creatorcontrib>Duffy, Patrick E</creatorcontrib><creatorcontrib>Borkowsky, William</creatorcontrib><creatorcontrib>For The P S Study Team</creatorcontrib><title>Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy</title><title>The American journal of tropical medicine and hygiene</title><addtitle>Am J Trop Med Hyg</addtitle><description>Laboratory data and prior pediatric reports indicate that HIV protease inhibitor (PI)-based antiretroviral therapy (ARV) kills gametocytes and reduces rates of gametocytemia, but not asymptomatic parasitemia, in a high malaria-transmission area. To determine whether ARV regimen impacts these rates in areas with less-intense malaria transmission, we compared asymptomatic parasitemia and gametocytemia rates in HIV-infected children by ARV regimen in Lilongwe, Malawi, an area of low-to-moderate transmission intensity. HIV PI lopinavir-ritonavir (LPV-rtv) ARV- or non-nucleoside reverse transcriptase inhibitor nevirapine ARV-treated children did not differ in the rates of polymerase chain reaction-detected asymptomatic parasitemia (relative risk [RR] 0.43 95% confidence interval [CI] [0.16, 1.18], value 0.10) or microscopically detected gametocytemia with LPV-rtv ARV during symptomatic malaria (RR 0.48 95% CI [0.22,1.04] value 0.06). LPV-rtv ARV was not associated with reduced rates of asymptomatic parasitemia, or gametocytemia on days of symptomatic malaria episodes, in HIV-infected children. Larger studies should evaluate whether ARV impacts transmission.</description><subject>Africa South of the Sahara - epidemiology</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral drugs</subject><subject>Asymptomatic Infections - epidemiology</subject><subject>Child, Preschool</subject><subject>Coinfection - epidemiology</subject><subject>Coinfection - parasitology</subject><subject>Coinfection - virology</subject><subject>Drug therapy</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - parasitology</subject><subject>Humans</subject><subject>Infant</subject><subject>Malaria</subject><subject>Malaria, Falciparum - complications</subject><subject>Malaria, Falciparum - epidemiology</subject><subject>Male</subject><subject>Microsatellite Repeats - genetics</subject><subject>Parasitemia - epidemiology</subject><subject>Plasmodium falciparum - genetics</subject><subject>Prevalence</subject><subject>Protease inhibitors</subject><issn>0002-9637</issn><issn>1476-1645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkc1vEzEQxS0EoqFw5IosceGyxR_r9fqCFAXaRqpED4Wr5XXGjaNdO9jeSPnvcZtSAaeRZn56mvceQu8puWhZpz6bXZm2F1Q2pO3YC7Sgrewa2rXiJVoQQlijOi7P0Jucd4TQnlH6Gp0xRTvBmFig-TbBwYwQLODo8DIfp32Jkyne4luTTPYFJm-wCRt8ZSYo0R5PGx_w9fpnsw4ObIENXm39uEkQcAz4q3cOkg_3eBmKT1BSPPhkRny3hWT2x7folTNjhndP8xz9uPx2t7pubr5frVfLm8a2VJSGEhgUcc70PbNWKGkFkYORshXccGGJ7SkzwC13LRkcs9V7R9XQQksEVOgcfTnp7udhgo2FUOoXep_8ZNJRR-P1v5fgt_o-HrRQrJeMVIFPTwIp_pohFz35bGEcTYA4Z01VJ2vunNCKfvwP3cU5hWpP19A7IhTnqlLNibIp5pzAPT9DiX4oVD8WqqnUD4VW_sPfDp7pPw3y37nynp8</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Hobbs, Charlotte V</creator><creator>Gabriel, Erin E</creator><creator>Kamthunzi, Portia</creator><creator>Tegha, Gerald</creator><creator>Tauzie, Jean</creator><creator>Li, Yonghua</creator><creator>Ilmet, Tiina</creator><creator>Artimovich, Elena</creator><creator>Neal, Jillian</creator><creator>Hall, Ted</creator><creator>Parikh, Sunil</creator><creator>Kirmse, Brian</creator><creator>Jean-Philippe, Patrick</creator><creator>Chen, Jingyang</creator><creator>Prescott, William R</creator><creator>Palumbo, Paul</creator><creator>Duffy, Patrick E</creator><creator>Borkowsky, William</creator><creator>For The P S Study Team</creator><general>Institute of Tropical Medicine</general><general>The American Society of Tropical Medicine and Hygiene</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy</title><author>Hobbs, Charlotte V ; Gabriel, Erin E ; Kamthunzi, Portia ; Tegha, Gerald ; Tauzie, Jean ; Li, Yonghua ; Ilmet, Tiina ; Artimovich, Elena ; Neal, Jillian ; Hall, Ted ; Parikh, Sunil ; Kirmse, Brian ; Jean-Philippe, Patrick ; Chen, Jingyang ; Prescott, William R ; Palumbo, Paul ; Duffy, Patrick E ; Borkowsky, William ; For The P S Study Team</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-10eb90ffa882cc597c507ba77453a35c0c812ae3c3f40bf2c476619b4e405e453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Africa South of the Sahara - epidemiology</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral drugs</topic><topic>Asymptomatic Infections - epidemiology</topic><topic>Child, Preschool</topic><topic>Coinfection - epidemiology</topic><topic>Coinfection - parasitology</topic><topic>Coinfection - virology</topic><topic>Drug therapy</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - parasitology</topic><topic>Humans</topic><topic>Infant</topic><topic>Malaria</topic><topic>Malaria, Falciparum - complications</topic><topic>Malaria, Falciparum - epidemiology</topic><topic>Male</topic><topic>Microsatellite Repeats - genetics</topic><topic>Parasitemia - epidemiology</topic><topic>Plasmodium falciparum - genetics</topic><topic>Prevalence</topic><topic>Protease inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hobbs, Charlotte V</creatorcontrib><creatorcontrib>Gabriel, Erin E</creatorcontrib><creatorcontrib>Kamthunzi, Portia</creatorcontrib><creatorcontrib>Tegha, Gerald</creatorcontrib><creatorcontrib>Tauzie, Jean</creatorcontrib><creatorcontrib>Li, Yonghua</creatorcontrib><creatorcontrib>Ilmet, Tiina</creatorcontrib><creatorcontrib>Artimovich, Elena</creatorcontrib><creatorcontrib>Neal, Jillian</creatorcontrib><creatorcontrib>Hall, Ted</creatorcontrib><creatorcontrib>Parikh, Sunil</creatorcontrib><creatorcontrib>Kirmse, Brian</creatorcontrib><creatorcontrib>Jean-Philippe, Patrick</creatorcontrib><creatorcontrib>Chen, Jingyang</creatorcontrib><creatorcontrib>Prescott, William R</creatorcontrib><creatorcontrib>Palumbo, Paul</creatorcontrib><creatorcontrib>Duffy, Patrick E</creatorcontrib><creatorcontrib>Borkowsky, William</creatorcontrib><creatorcontrib>For The P S Study Team</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of tropical medicine and hygiene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hobbs, Charlotte V</au><au>Gabriel, Erin E</au><au>Kamthunzi, Portia</au><au>Tegha, Gerald</au><au>Tauzie, Jean</au><au>Li, Yonghua</au><au>Ilmet, Tiina</au><au>Artimovich, Elena</au><au>Neal, Jillian</au><au>Hall, Ted</au><au>Parikh, Sunil</au><au>Kirmse, Brian</au><au>Jean-Philippe, Patrick</au><au>Chen, Jingyang</au><au>Prescott, William R</au><au>Palumbo, Paul</au><au>Duffy, Patrick E</au><au>Borkowsky, William</au><au>For The P S Study Team</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy</atitle><jtitle>The American journal of tropical medicine and hygiene</jtitle><addtitle>Am J Trop Med Hyg</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>98</volume><issue>1</issue><spage>67</spage><epage>70</epage><pages>67-70</pages><issn>0002-9637</issn><eissn>1476-1645</eissn><abstract>Laboratory data and prior pediatric reports indicate that HIV protease inhibitor (PI)-based antiretroviral therapy (ARV) kills gametocytes and reduces rates of gametocytemia, but not asymptomatic parasitemia, in a high malaria-transmission area. To determine whether ARV regimen impacts these rates in areas with less-intense malaria transmission, we compared asymptomatic parasitemia and gametocytemia rates in HIV-infected children by ARV regimen in Lilongwe, Malawi, an area of low-to-moderate transmission intensity. HIV PI lopinavir-ritonavir (LPV-rtv) ARV- or non-nucleoside reverse transcriptase inhibitor nevirapine ARV-treated children did not differ in the rates of polymerase chain reaction-detected asymptomatic parasitemia (relative risk [RR] 0.43 95% confidence interval [CI] [0.16, 1.18], value 0.10) or microscopically detected gametocytemia with LPV-rtv ARV during symptomatic malaria (RR 0.48 95% CI [0.22,1.04] value 0.06). LPV-rtv ARV was not associated with reduced rates of asymptomatic parasitemia, or gametocytemia on days of symptomatic malaria episodes, in HIV-infected children. Larger studies should evaluate whether ARV impacts transmission.</abstract><cop>United States</cop><pub>Institute of Tropical Medicine</pub><pmid>29165225</pmid><doi>10.4269/ajtmh.17-0462</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9637
ispartof The American journal of tropical medicine and hygiene, 2018-01, Vol.98 (1), p.67-70
issn 0002-9637
1476-1645
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5928720
source PubMed Central Free
subjects Africa South of the Sahara - epidemiology
Anti-HIV Agents - therapeutic use
Antiretroviral drugs
Asymptomatic Infections - epidemiology
Child, Preschool
Coinfection - epidemiology
Coinfection - parasitology
Coinfection - virology
Drug therapy
Female
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - parasitology
Humans
Infant
Malaria
Malaria, Falciparum - complications
Malaria, Falciparum - epidemiology
Male
Microsatellite Repeats - genetics
Parasitemia - epidemiology
Plasmodium falciparum - genetics
Prevalence
Protease inhibitors
title Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A53%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Asymptomatic%20Parasitemia%20and%20Gametocytemia%20in%20HIV-Infected%20Children%20on%20Differing%20Antiretroviral%20Therapy&rft.jtitle=The%20American%20journal%20of%20tropical%20medicine%20and%20hygiene&rft.au=Hobbs,%20Charlotte%20V&rft.date=2018-01-01&rft.volume=98&rft.issue=1&rft.spage=67&rft.epage=70&rft.pages=67-70&rft.issn=0002-9637&rft.eissn=1476-1645&rft_id=info:doi/10.4269/ajtmh.17-0462&rft_dat=%3Cproquest_pubme%3E2116059339%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-10eb90ffa882cc597c507ba77453a35c0c812ae3c3f40bf2c476619b4e405e453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2116059339&rft_id=info:pmid/29165225&rfr_iscdi=true